Back

Landmark, Hotline & Late Breaking Trials - Betablockers, CCS Trials, Post-MI Treatment - Discussion.

27 September 2025 (19:15 - 19:45)
Organised by: Logo
Seminar Presentation Part of: Landmark, Hotline & Late Breaking Trials - Betablockers, CCS Trials, Post-MI Treatment Cardiovascular Pharmacotherapy ESC Premium Access Best of ESC Congress 2025 - India European Society of Cardiology

2 More presentations in this session

Presentation thumbnail
Landmark, Hotline & Late Breaking Trials - Betablockers, CCS Trials, Post-MI Treatment.
Slides
Presentation thumbnail
Landmark, Hotline & Late Breaking Trials - Betablockers, CCS Trials, Post-MI Treatment - Session Summary.

Access the full session

Session thumbnail
Landmark, Hotline & Late Breaking Trials - Betablockers, CCS Trials, Post-MI Treatment
Video

The Event

Event poster

Best of ESC Congress 2025 - India

27 September 2025 19:15 CET
You may be interested in
thumbnail
Congress Presentation
Discussant review - REBOOT-CNIC, BETAMI-DANBLOCK, CAPITAL-RCT
30 August 2025
thumbnail
Congress Session
Hottest trials and trial updates (2)
18 May 2025
thumbnail
Congress Presentation
Efficacy of early intravenous landiolol, an ultrashort-acting beta-blocker on infarct size and its safety in patients with myocardial infarction undergoing primary PCI: a randomized, controlled study
28 August 2020
thumbnail
Congress Presentation
Heart rate and cardiovascular outcomes with and without beta-blocker in post-mi patients: a pre-specified analysis of the ABYSS trial.
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources